Search Results - "Sadat, Sams M. A"
-
1
Potentiating Antigen Specific Immune Response by Targeted Delivery of the PLGA-Based Model Cancer Vaccine
Published in Molecular pharmaceutics (04-02-2019)“…Targeted delivery of vaccine has the potential to localize the therapeutic agent to a target tissue with minimum side-effects. This article presents the…”
Get full text
Journal Article -
2
Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer
Published in Journal of Drug Delivery (01-01-2017)“…In nanomedicine, targeted therapeutic nanoparticle (NP) is a virtual outcome of nanotechnology taking the advantage of cancer propagation pattern. Tying up all…”
Get full text
Journal Article -
3
Development of Self-Associating SN-38-Conjugated Poly(ethylene oxide)-Poly(ester) Micelles for Colorectal Cancer Therapy
Published in Pharmaceutics (29-10-2020)“…The clinical use of 7-ethyl-10-hydroxy-camptothecin (SN-38), which is the active metabolite of irinotecan, has been hampered because of its practical…”
Get full text
Journal Article -
4
Nano-Delivery of a Novel Inhibitor of Polynucleotide Kinase/Phosphatase (PNKP) for Targeted Sensitization of Colorectal Cancer to Radiation-Induced DNA Damage
Published in Frontiers in oncology (23-12-2021)“…Inhibition of the DNA repair enzyme polynucleotide kinase/phosphatase (PNKP) increases the sensitivity of cancer cells to DNA damage by ionizing radiation…”
Get full text
Journal Article -
5
Local innate responses and protective immunity after intradermal immunization with bovine viral diarrhea virus E2 protein formulated with a combination adjuvant in cattle
Published in Vaccine (14-06-2017)“…Abstract Bovine viral diarrhea virus (BVDV) is one of the most serious pathogens in cattle. Recently, we developed a novel adjuvant platform (TriAdj) that…”
Get full text
Journal Article -
6
Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3′-Phosphatase (PNKP) for Enhanced Treatment of Colorectal Cancer
Published in Molecular pharmaceutics (01-07-2024)“…Inhibitors of a DNA repair enzyme known as polynucleotide kinase 3′-phosphatase (PNKP) are expected to show synergistic cytotoxicity in combination with…”
Get full text
Journal Article -
7
A synthetically lethal nanomedicine delivering novel inhibitors of polynucleotide kinase 3′-phosphatase (PNKP) for targeted therapy of PTEN-deficient colorectal cancer
Published in Journal of controlled release (10-06-2021)“…Phosphatase and TENsin homolog deleted on chromosome 10 (PTEN) is a major tumor-suppressor protein that is lost in up to 75% of aggressive colorectal cancers…”
Get full text
Journal Article -
8
Nano-pharmaceutical formulations for targeted drug delivery against HER2 in breast cancer
Published in Current cancer drug targets (01-01-2015)“…Nanotechnology has revolutionized fundamental opportunities for higher specific drug delivery with minimum side effects. Since its inception, the goal of…”
Get more information
Journal Article -
9
Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine
Published in International journal of nanomedicine (01-01-2018)“…The aim of this research was to develop a targeted antigen-adjuvant assembled delivery system that will enable dendritic cells (DCs) to efficiently mature to…”
Get full text
Journal Article